Insulet Corporation

PODD Healthcare Medical Devices

Insulet Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 30.7% from fiscal 2024. In the quarter to June 2026, revenue grew 23.5%, EPS grew 328.1%, free cash flow fell 70.5% and total debt fell 32.2%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

141.10 2.33 +1.68%
Market cap
$9.6B
P/E
26.4×
Fwd P/E
24.7×
Dividend yield
—
F-score
6/9
Altman Z
9.09
Beneish M
−2.59
Dividend safety
n/a

Insulet Corporation (PODD) Book value per share

Alert me on Book value per share

Insulet Corporation's book value per share at the end of fiscal 2025 was 21.5×, up 24.6% from 17.3× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 20.5×. Over the past ten years it has ranged from 0.6× (fiscal 2015) to 21.5× (fiscal 2025) — the current reading is the highest in ten years. Insulet Corporation ranks 21st of 149 Medical Devices companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 21.5× 24.57%
FY2024 17.3× 64.59%
FY2023 10.5× 52.97%
FY2022 6.9× (16.43%)
FY2021 8.2× (11.87%)
FY2020 9.3× 644.39%
FY2019 1.3× (65.24%)
FY2018 3.6× 31.86%
FY2017 2.7× 147.77%
FY2016 1.1× 83.96%

Quarterly newest first

Period Book value per share Change
Jun 2026 20.5× 10.27%
Mar 2026 18.6× (13.59%)
Dec 2025 21.5× 9.50%
Sep 2025 19.7× (5.36%)
42 more quarters

Against its own ten years

Low 0.6× High 21.5×
Ten-year median 6.9×
Current reading's percentile 100

Book value per share against peers

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on PODD